# NORM-HF Pivotal Study

Study · id `cardio:ct-nct07574593` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07574593](<https://clinicaltrials.gov/study/NCT07574593>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07574593

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 800 participants.

## Technical summary

Registry record NCT07574593. Randomized; no masking; primary purpose prevention. Start 2026-05-29 (actual); primary completion 2029-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT07574593, source copy `cardio:ctgov-nct07574593-2026-10-16`, retrieved 2026-10-26)
- Started: 2026-05-29 (actual) (ClinicalTrials.gov record NCT07574593, source copy `cardio:ctgov-nct07574593-2026-10-16`, retrieved 2026-10-26)
- Primary completion: 2029-08 (anticipated) (ClinicalTrials.gov record NCT07574593, source copy `cardio:ctgov-nct07574593-2026-10-16`, retrieved 2026-10-26)
- Completion: 2033-12 (anticipated) (ClinicalTrials.gov record NCT07574593, source copy `cardio:ctgov-nct07574593-2026-10-16`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07574593, source copy `cardio:ctgov-nct07574593-2026-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07574593-2026-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: NORM-HF Pivotal Study
- Acronym: NORM-HF
- Condition: Heart Failure
- Condition: NYHA Class III Heart Failure
- Condition: NYHA Class II Heart Failure
- Intervention (Device): IVC Sensor
- Lead sponsor: Foundry Innovation & Research 1, Limited (FIRE1)
- Lead sponsor class: INDUSTRY
- Collaborator: NAMSA
- Collaborator class: OTHER
- Collaborator: Baim Institute for Clinical Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Baim Institute for Clinical Research (`cardio:org-baim-institute-for-clinical-research`)

## Provenance

Content hash: 3d964eac6a714e38dbcc00f65d9ecb7db164075a8213deccf8c0987c00425554
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
